Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Group Regulatory News (SAG)

Share Price Information for Science Group (SAG)

Share Price is delayed by 15 minutes
Get Live Data
585.00    0.00 (0.00%)
Bid:
580.00
Ask:
590.00
Spread: 10.00 (1.724%)
Market Cap: £239.60m
SAG Live PriceLast checked at - London Stock Exchange

Intraday Science Group Share Chart

Form 8 (DD) - TP Group plc

1 Nov 2022 07:00

RNS Number : 8180E
Science Group PLC
01 November 2022
Β 

FORM 8 (DD)

Β 

PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS)

Rules 8.1, 8.2 and 8.4 of the Takeover Code (the "Code")

Β 

1. KEY INFORMATION

Β 

(a) Full name of discloser:

Science Group plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

TP Group plc

(d) Status of person making the disclosure:

e.g. offeror, offeree, person acting in concert with the offeror/offeree (specify name of offeror/offeree)

Offeror

(e) Date dealing undertaken:

31 October 2022

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

Β 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

Β 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Β 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing

Β 

Class of relevant security:

Β 

Β 

Β 

Β 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

219,065,919

28.11

Β 

Β 

(2) Cash-settled derivatives:

Β 

Nil

0.00

Β 

Β 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

0.00

Β 

Β 

Β 

TOTAL:

219,065,919

28.11

Β 

Β 

Β 

All interests and all short positions should be disclosed.

Β 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental FormΒ 8 (Open Positions).

Β 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

Β 

(b) Rights to subscribe for new securities (including directors' and other employee options)

Β 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

Β 

3. DEALINGS BY THE PERSON MAKING THE DISCLOSURE

Β 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

Β 

The currency of all prices and other monetary amounts should be stated.

Β 

(a) Purchases and sales

Β 

(i) Party to an offer or person acting in concert (except for a principal trader in the same group as a connected adviser)

Β 

Class of relevant security

Purchase/sale

Β 

Number of securities

Price per unit

1p Ordinary

Purchase

Β 

46,970

2.172p

1p Ordinary

Purchase

Β 

500,000

2.155p

1p Ordinary

Purchase

Β 

20,000

2.157p

1p Ordinary

Purchase

Β 

13,105

2.173p

1p Ordinary

Purchase

Β 

562,739

2.175p

Β 

(ii) Principal trader where the sole reason for the connection is that the principal trader is in the same group as a connected adviser

Β 

Class of relevant security

Purchases/ sales

Β 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

N/A

N/A

Β 

N/A

N/A

N/A

Β 

(b) Cash-settled derivative transactions

Β 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

N/A

N/A

Β 

N/A

N/A

N/A

Β 

(c) Stock-settled derivative transactions (including options)

Β 

(i) Writing, selling, purchasing or varying

Β 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

N/A

N/A

Β 

N/A

N/A

N/A

N/A

N/A

N/A

Β 

(ii) Exercise

Β 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

N/A

N/A

Β 

N/A

N/A

N/A

Β 

(d) Other dealings (including subscribing for new securities)

Β 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

N/A

Β 

N/A

N/A

N/A

Β 

Β 

4. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer or person acting in concert making the disclosure and any other person:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

N/A

Β 

Β 

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer or person acting in concert making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

Β 

N/A

Β 

Β 

(c) Attachments

Β 

Are any Supplemental Forms attached?

Β 

Supplemental Form 8 (Open Positions)

No

Supplemental Form 8 (SBL)

No

Β 

Β 

Date of disclosure:

1 November 2022

Contact name:

Sarah Cole

Group Legal Counsel & Company Secretary

Telephone number:

01223 875 200

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

Β 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DCCFDEESFEESEDS
Date   Source Headline
5th Jun 20257:00 amRNSTransaction in Own Shares
4th Jun 20257:00 amRNSTransaction in Own Shares
3rd Jun 20257:00 amRNSTransaction in Own Shares
2nd Jun 20257:01 amRNS-RRicardo EGM – ISS Recommendation
2nd Jun 20257:00 amRNSTotal Voting Rights
28th May 202511:03 amRNSHolding(s) in Company
28th May 20257:00 amRNSRicardo Investment and Open Letter
23rd May 20257:00 amRNSTransaction in Own Shares
22nd May 20257:00 amRNSTransaction in Own Shares
21st May 202510:30 amRNSResult of AGM
21st May 20257:01 amRNSAGM Update
21st May 20257:00 amRNSTransaction in Own Shares
16th May 20257:00 amRNSTransaction in Own Shares
14th May 20257:00 amRNSTransaction in Own Shares
12th May 20257:01 amRNSTreasury shares issued
12th May 20257:00 amRNSIssue of share options and PDMR dealing
8th May 20257:00 amRNSTransaction in Own Shares
1st May 20257:34 amRNSRicardo Investment Update and GM Requisition
1st May 20257:00 amRNSTotal Voting Rights
30th Apr 20257:00 amRNSTransaction in Own Shares
29th Apr 20257:00 amRNSTransaction in Own Shares
24th Apr 20257:01 amRNSQ1 Trading Update and Response to Ricardo BSU
24th Apr 20257:00 amRNSTransaction in Own Shares
23rd Apr 20257:00 amRNSTransaction in Own Shares
22nd Apr 20257:00 amRNSTransaction in Own Shares
17th Apr 20257:00 amRNSTransaction in Own Shares
16th Apr 20257:00 amRNSTransaction in Own Shares
15th Apr 20257:00 amRNSNotice of Annual General Meeting
14th Apr 20257:00 amRNSTransaction in Own Shares
11th Apr 20257:00 amRNSTransaction in Own Shares
10th Apr 20257:00 amRNSTransaction in Own Shares
9th Apr 20257:00 amRNSTransaction in Own Shares
8th Apr 202510:03 amRNSHolding(s) in Company
8th Apr 20257:01 amRNSShareholding in Ricardo over 20%
8th Apr 20257:00 amRNSTransaction in Own Shares
7th Apr 202512:05 pmRNSExecutive Chair Share Purchase
7th Apr 20257:00 amRNSTransaction in Own Shares
4th Apr 202512:05 pmRNSHolding(s) in Company
4th Apr 20257:00 amRNSIncreased Shareholding in Ricardo plc
3rd Apr 20257:00 amRNSTransaction in Own Shares
1st Apr 20257:01 amRNSIncreased Shareholding in Ricardo plc
1st Apr 20257:00 amRNSTransaction in Own Shares & Total Voting Rights
31st Mar 20255:35 pmRNSHolding(s) in Company
31st Mar 20257:01 amRNS-RUpdate on Ricardo plc
31st Mar 20257:00 amRNSTransaction in Own Shares
28th Mar 20257:00 amRNSTreasury shares issued
27th Mar 20259:21 amRNSTransaction in Own Shares
27th Mar 20257:00 amRNSExecutive Chair Share Purchase
26th Mar 20257:00 amRNSExecutive Chair Share Purchase
25th Mar 20252:20 pmRNSDirector Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.